Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2018

Oct 15, 2018

SELL
$88.86 - $117.49 $133,290 - $176,235
-1,500 Closed
0 $0
Q2 2018

Jul 09, 2018

BUY
$99.64 - $127.59 $59,784 - $76,554
600 Added 66.67%
1,500 $5,000
Q1 2018

May 01, 2018

BUY
$105.8 - $150.94 $95,220 - $135,846
900 New
900 $0

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.